Wearable Devices Announces First Half 2025 Financial Results
Rhea-AI Summary
Wearable Devices (NASDAQ:WLDS) reported its H1 2025 financial results, marking its commercial debut with the Mudra Link wristband. The company generated revenues of $294,000 from B2C sales and B2B collaborations, though this represents a decrease from $394,000 in H1 2024. Net loss improved to $3.7 million ($2.3 per share) compared to $4.2 million ($16.52 per share) in H1 2024.
Key developments include launching Mudra Link for Android devices, expanding into Japan through a partnership with Media Exceed, releasing updates for Mac/Windows users, and initiating a military project for touchless neural control systems. The company also strengthened its patent portfolio in neural interface capabilities and gesture recognition technology.
Positive
- None.
Negative
- Revenue declined 25.4% year-over-year to $294,000 from $394,000
- Still operating at significant losses with $3.7 million net loss in H1 2025
- Increased operating expenses in R&D, sales and marketing, and general administration
News Market Reaction
On the day this news was published, WLDS gained 407.84%, reflecting a significant positive market reaction. Argus tracked a peak move of +836.5% during that session. Our momentum scanner triggered 29 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $20M to the company's valuation, bringing the market cap to $25M at that time. Trading volume was exceptionally heavy at 212.8x the daily average, suggesting very strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
During this period, the Company started generating revenues from commercial sales of its Mudra Link, a universal gesture control wristband
YOKNE’AM ILLIT, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced its financial results for the six months ended June 30, 2025, marking its commercial debut with the innovative Mudra Link wristband.
Management Commentary:
“We are excited to kick off 2025 with strong revenue momentum from the Mudra Link and Mudra Band, alongside a significantly reduced net loss compared to last year,” said Asher Dahan, Chairman and Chief Executive Officer of Wearable Devices. “This reflects our foothold in the global wearable tech market, a dynamic sector, as demand for intuitive, touchless interfaces skyrockets. In the first half of 2025, we started the delivery of Mudra Link, a universal gesture control wearable wristband, in addition to continued recognition of revenue from the sale of Mudra Band for Apple Watch, the Company’s B2C products. After a preorder period during which the Mudra Link generated strong customer interest, we began shipping the product at the beginning of 2025 and are pleased to have reached this important milestone.”
Mr. Dahan added: “We continue to invest in our business, as reflected in the modest increases in research and development, sales and marketing, and general and administrative expenses in the period. We’re still in the early stages of growth in the broader wearables industry, and we believe that Wearable Devices is well-positioned to be a leader in the space given our patented AI-based neural input interface technology.
Wearable Devices is riding the wave of a wearable tech revolution, with applications spanning consumer gadgets, military interfaces, and health analytics. The Company is cementing its role as a key player, leveraging AI innovation to meet this surging demand and deliver shareholder value.
The Japan collaboration taps into a tech-savvy market, while the LMM’s potential in cognitive state monitoring positions the Company to penetrate the health wearable market by 2026. Strategic B2B deals, like the military project, could unlock multi-million-dollar contracts as defense sectors prioritize touchless controls.”
First Half 2025 Financial Results and Recent Company Highlights:
- Revenues:
$294,000 from the initial B2C sale of Mudra Link, continuous revenues from Mudra Band for Apple Watch, and B2B collaborations, marking a strategic expansion with Mudra Link’s launch. This reflects Wearable Devices’ new capability to serve both Android and iOS devices, broadening its market reach with a universal neural interface wristband and Apple Watch accessory. - Patents Strategy: In 2025, Wearable Devices executed a dynamic and forward-focused patent strategy, which protects core neural interface capabilities and enhances gesture recognition by accurately defining gesture start and end points- eliminating the need for buttons. These patents form the foundation of the Company’s broader IP roadmap, building a broad, adaptable, and defensible global portfolio that covers future wearable bio-potential applications. This strategy positions Wearable Devices to capitalize across consumer XR, industrial automation, and assistive technology markets while safeguarding its technological leadership.
- Launched a new innovative and disruptive product- the Mudra Link: Officially launched the Mudra Link, the first AI neural interface wristband for Android and beyond, providing advanced neural input technology for Android users.
- Entering the Japanese Tech-Savvy Market with new collaboration with Media Exceed Co., Ltd. (“Media Exceed”), a leading e-commerce company in Japan. Under this agreement, Media Exceed will serve as a non-exclusive reseller of the award-winning Mudra Band and Mudra Link, bringing Wearable Devices’ innovative neural technology to Japan.
- Released a new Mudra Link update for Mac and Windows users, transforming it into a personalized neural wristband controller worn on the wrist as well as other significant enhancements.
- Launched an innovative project to advance human-machine interfaces for military applications. This cutting-edge initiative introduces a touchless neural control system that would enable soldiers to operate critical tactical systems seamlessly, enhancing operational efficiency and safety in high-stakes environments.
In the first half of 2025, Wearable Devices started delivering and recognizing revenues from the Mudra Link, a universal gesture control wearable wristband, in addition to continued recognition of revenue from the sale of Mudra Band for Apple Watch, the Company’s B2C products. Revenues for the six months ended June 30, 2025 were
About Wearable Devices Ltd.
Wearable Devices Ltd. is a growth company developing AI-based neural input interface technology for the B2C and B2B markets. The Company’s flagship product, the Mudra Band for Apple Watch, integrates innovative AI-based technology and algorithms into a functional, stylish wristband that utilizes proprietary sensors to identify subtle finger and wrist movements allowing the user to “touchlessly” interact with connected devices. The Company also markets a B2B product, which utilizes the same technology and functions as the Mudra Band and is available to businesses on a licensing basis. Wearable Devices Is committed to creating disruptive, industry leading technology that leverages AI and proprietary algorithms, software, and hardware to set the input standard for the Extended Reality, one of the most rapidly expanding landscapes in the tech industry. The Company’s ordinary shares and warrants trade on the Nasdaq market under the symbols “WLDS” and “WLDSW”, respectively.
Forward-Looking Statement Disclaimer
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. For example, we are using forward-looking statements when we discuss our belief that we are well-positioned to be a leader in the space of wearable devices; that we are cementing our role as a key player, leveraging AI innovation to meet this surging demand and deliver shareholder value; the LMM’s potential in cognitive state monitoring positions us to penetrate the health wearable market by 2026; that strategic B2B deals, like the military project, could unlock multi-million-dollar contracts as defense sectors prioritize touchless controls; that our IP strategy positions us to capitalize across consumer XR, industrial automation, and assistive technology markets while safeguarding our technological leadership and the benefits and advantages of our technology and products. All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the trading of our ordinary shares or warrants and the development of a liquid trading market; our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, strategic alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our annual report on Form 20-F for the year ended December 31, 2024, filed on March 20, 2025 and our other filings with the SEC. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Investor Relations Contact
Michal Efraty
| INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) | |||||
| U.S. dollars (in thousands) | |||||
| June 30, | December 31, | ||||
| 2025 | 2024 | ||||
| ASSETS | |||||
| CURRENT ASSETS: | |||||
| Cash and cash equivalents | 2,064 | 3,089 | |||
| Short-term bank deposits | 1,392 | 862 | |||
| Governmental grant receivable | - | 17 | |||
| Other receivables and prepaid expenses | 133 | 322 | |||
| Inventories | 928 | 1,226 | |||
| TOTAL CURRENT ASSETS | 4,517 | 5,516 | |||
| NON-CURRENT ASSETS: | |||||
| Right-of-use assets | 181 | 330 | |||
| Property and equipment, net | 89 | 130 | |||
| TOTAL NON-CURRENT ASSETS | 270 | 460 | |||
| TOTAL ASSETS | 4,787 | 5,976 | |||
| INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) | |||||
| U.S. dollars (in thousands) | |||||
| June 30, | December 31, | ||||
| 2025 | 2024 | ||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||
| CURRENT LIABILITIES: | |||||
| Accounts payables | 93 | 157 | |||
| Advance payments | 12 | 83 | |||
| Convertible promissory note | - | 770 | |||
| Accrued payroll and other employment related accruals | 541 | 402 | |||
| Accrued expenses | 165 | 392 | |||
| Lease liabilities | 163 | 291 | |||
| TOTAL CURRENT LIABILITIES | 974 | 2,095 | |||
| Lease liabilities | - | 21 | |||
| TOTAL LIABILITIES | 974 | 2,116 | |||
| SHAREHOLDERS' EQUITY | |||||
| Ordinary shares, NIS 0.01 par value: | |||||
| Authorized 50,000,000 as of June 30, 2025 and December 31, 2024; issued and outstanding 2,287,833 shares as of June 30, 2025 and 707,463 shares as of December 31, 2024 | 67 | 67 | |||
| Additional paid-in capital | 36,563 | 32,895 | |||
| Accumulated losses | (32,817 | ) | (29,102 | ) | |
| TOTAL SHAREHOLDERS’ EQUITY | 3,813 | 3,860 | |||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | 4,787 | 5,976 | |||
| INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) | |||||
| Six months ended June 30, 2025 | Six months ended June 30, 2024 | ||||
| U.S. dollars in thousands (except per share amounts) | |||||
| Revenues | 294 | 394 | |||
| Expenses: | |||||
| Cost of revenues | (272 | ) | (315 | ) | |
| Impairment of product sales inventory | (175 | ) | - | ||
| Research and development, net | (1,466 | ) | (1,616 | ) | |
| Sales and marketing expenses | (919 | ) | (1,083 | ) | |
| General and administrative expenses | (1,220 | ) | (1,601 | ) | |
| OPERATING LOSS | (3,758 | ) | (4,221 | ) | |
| FINANCING INCOME, NET | 48 | 11 | |||
| LOSS BEFORE TAXES | (3,710 | ) | (4,210 | ) | |
| Tax expenses | (5 | ) | - | ||
| NET LOSS AND TOTAL COMPREHENSIVE LOSS | (3,715 | ) | (4,210 | ) | |
| Net loss per ordinary share, basic and diluted | (2.3 | ) | (16.52 | ) | |
| Weighted average number of ordinary shares outstanding basic and diluted | 1,404,346 | 254,912 | |||
| U.S. dollars (in thousands) | |||||||
| INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) U.S. dollars (in thousands) | |||||||
| Six months ended June 30, | |||||||
| 2025 | 2024 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net loss | (3,715 | ) | (4,210 | ) | |||
| Adjustments required to reconcile net loss to net cash used in operating activities | |||||||
| Depreciation | 48 | 54 | |||||
| Accrued interest on deposits | (7 | ) | 39 | ||||
| Interest expenses on convertible promissory note | - | 14 | |||||
| Share-based compensation expenses | 427 | 112 | |||||
| Provision for inventory write-off | 175 | - | |||||
| Unrealized gain from foreign currency derivative activities | - | 61 | |||||
| Changes in operating assets and liabilities items: | |||||||
| Decrease (increase) in inventory | 123 | (186 | ) | ||||
| Increase in accounts receivables | - | (47 | ) | ||||
| Decrease in governmental grants receivables | 17 | 101 | |||||
| Decrease in other receivables and prepaid expenses | 189 | 380 | |||||
| Decrease in advance payments | (72 | ) | (211 | ) | |||
| Decrease in accounts payable | (64 | ) | (236 | ) | |||
| Increase in accrued payroll and other employment related accruals | 138 | 62 | |||||
| Increase (decrease) in accrued expenses | (226 | ) | 206 | ||||
| Net cash used in operating activities | (2,967 | ) | (3,861 | ) | |||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Purchase of property and equipment | (7 | ) | (36 | ) | |||
| Proceeds (investments) associated with deposits, net | (522 | ) | 4,003 | ||||
| Net cash (used in) provided by investing activities | (529 | ) | 3,967 | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Proceeds from issuance of convertible promissory note | - | 1,920 | |||||
| Repayment of convertible promissory note | (770 | ) | - | ||||
| Proceeds from issuance of ordinary shares associated to best effort deal | 2,200 | - | |||||
| Proceeds from issuance of ordinary shares under inducement offer letter agreement | 1,041 | - | |||||
| Proceeds from issuance of ordinary shares associated with the SEPA | - | 267 | |||||
| Net cash provided by financing activities | 2,471 | 2,187 | |||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (1,025 | ) | 2,293 | ||||
| CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 3,089 | 810 | |||||
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | 2,064 | 3,103 | |||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | |||||||
| Interest received from deposits | 77 | 110 | |||||
FAQ
What were Wearable Devices (WLDS) H1 2025 financial results?
What is the Mudra Link product launched by WLDS in 2025?
How has WLDS expanded its market presence in 2025?
What caused WLDS revenue decline in H1 2025?
What strategic initiatives has WLDS implemented in 2025?
